Plant-Based Online Weight Loss Through Education and Resources Program and Study
- NCT ID
- NCT07095543
- Registry status
- Recruiting
- Study type
- Not specified in the registry data
- Phase
- Not applicable
- Sponsor
- Physicians Committee for Responsible Medicine
Overview
ClinicalTrials.gov lists this study as Recruiting.
Enrollment: 100 participants (Estimated).
What is being studied
No interventions are listed in the registry data.
Who may be eligible
- Ages
- Not specified in the registry data
- Sex
- Not specified in the registry data
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Inclusion Criteria:
* U.S. men and women meeting the age of majority, defined as follows:
Age 19 or older in Nebraska and Alabama. Age 21 or older in Puerto Rico. Age 18 or older in all other states.
* Able and willing to travel to Washington DC for a dual-energy х-rау absorptiometry (DXA) scans before and after the program.
* Able and willing to complete laboratory assessments at a local LabCorp facility before and after the program.
* Able and willing to participate in all components of the study.
* BMI of 25 or more (23 or more in persons of Asian origin).
* Access to the internet.
* English fluency.
Exclusion Criteria:
* Use of recreational drugs in the past 6 months.
* Pregnancy or intention to become pregnant during the study period, as verified by self-report.
* Unstable medical or psychiatric illness.
* Inability to maintain medication regimen as prescribed by personal healthcare provider.
* Current or expected use of any weight loss medication during the study period, including but not limited to, glucagon-like peptide-1 (GLP-1) receptor agonists and combination GLP-1 receptor/glucose-dependent insulinotropic polypeptide (GIP) agonists.
* Use of any weight loss medication within the 12 months preceding the study period, including but not limited to, glucagon-like peptide-1 (GLP-1) receptor agonists and combination GLP-1 receptor/glucose-dependent insulinotropic polypeptide (GIP) agonists.
* Body weight greater than 182 kg.
* Current diagnosis of eating disorder.
* Intention to follow another weight loss method during the study period.
Study locations
1 study location is listed.
Site recruitment status is not specified in the registry data for these locations.
Countries: United States
- District of Columbia, United States: 1
Sample of listed locations
- Physicians Committee for Responsible Medicine — Washington D.C., District of Columbia, 20016, United States — Site recruitment status not specified in the registry data
Study details
- Start date
- January 2, 2026
- Primary completion date
- October 1, 2028
- First posted
- July 31, 2025
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07095543
- Registry last updated
- September 17, 2026
- QualifiedStudies registry data refreshed
- September 21, 2026
View NCT07095543 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Diabetes (Type II) studies | Clinical trial FAQ